310 related articles for article (PubMed ID: 33239400)
1. Implications of Oligomeric Amyloid-Beta (oAβ
George AA; Vieira JM; Xavier-Jackson C; Gee MT; Cirrito JR; Bimonte-Nelson HA; Picciotto MR; Lukas RJ; Whiteaker P
J Neurosci; 2021 Jan; 41(3):555-575. PubMed ID: 33239400
[TBL] [Abstract][Full Text] [Related]
2. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.
Liu Q; Huang Y; Xue F; Simard A; DeChon J; Li G; Zhang J; Lucero L; Wang M; Sierks M; Hu G; Chang Y; Lukas RJ; Wu J
J Neurosci; 2009 Jan; 29(4):918-29. PubMed ID: 19176801
[TBL] [Abstract][Full Text] [Related]
3. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
[TBL] [Abstract][Full Text] [Related]
4. Functional α7β2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid β peptides.
Liu Q; Huang Y; Shen J; Steffensen S; Wu J
BMC Neurosci; 2012 Dec; 13():155. PubMed ID: 23272676
[TBL] [Abstract][Full Text] [Related]
5. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
Liu Q; Xie X; Emadi S; Sierks MR; Wu J
Neuropharmacology; 2015 Oct; 97():457-63. PubMed ID: 25959067
[TBL] [Abstract][Full Text] [Related]
6. Analogs of α-conotoxin PnIC selectively inhibit α7β2- over α7-only subtype nicotinic acetylcholine receptors via a novel allosteric mechanism.
George AA; John SJ; Lucero LM; Eaton JB; Jaiswal E; Christensen SB; Gajewiak J; Watkins M; Cao Y; Olivera BM; Im W; McIntosh JM; Whiteaker P
FASEB J; 2024 Jan; 38(1):e23374. PubMed ID: 38161283
[TBL] [Abstract][Full Text] [Related]
7. The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.
Moretti M; Zoli M; George AA; Lukas RJ; Pistillo F; Maskos U; Whiteaker P; Gotti C
Mol Pharmacol; 2014 Sep; 86(3):306-17. PubMed ID: 25002271
[TBL] [Abstract][Full Text] [Related]
8. Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation.
Inestrosa NC; Godoy JA; Vargas JY; Arrazola MS; Rios JA; Carvajal FJ; Serrano FG; Farias GG
Neuromolecular Med; 2013 Sep; 15(3):549-69. PubMed ID: 23842742
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective amyloid β N-terminal peptides differentially alter human α7- and α7β2-nicotinic acetylcholine (nACh) receptor single-channel properties.
Roberts CF; Cao Y; Im W; Nichols RA; Lukas RJ; George AA
Br J Pharmacol; 2024 May; ():. PubMed ID: 38720171
[TBL] [Abstract][Full Text] [Related]
10. α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?
Hernandez CM; Dineley KT
Curr Drug Targets; 2012 May; 13(5):613-22. PubMed ID: 22300028
[TBL] [Abstract][Full Text] [Related]
11. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D
Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725
[TBL] [Abstract][Full Text] [Related]
12. Beta-amyloid peptide activates non-alpha7 nicotinic acetylcholine receptors in rat basal forebrain neurons.
Fu W; Jhamandas JH
J Neurophysiol; 2003 Nov; 90(5):3130-6. PubMed ID: 12890800
[TBL] [Abstract][Full Text] [Related]
13. LiCl attenuates impaired learning and memory of APP/PS1 mice, which in mechanism involves α7 nAChRs and Wnt/β-catenin pathway.
Xiang J; Ran LY; Zeng XX; He WW; Xu Y; Cao K; Dong YT; Qi XL; Yu WF; Xiao Y; Guan ZZ
J Cell Mol Med; 2021 Nov; 25(22):10698-10710. PubMed ID: 34708522
[TBL] [Abstract][Full Text] [Related]
14. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease.
Counts SE; He B; Che S; Ikonomovic MD; DeKosky ST; Ginsberg SD; Mufson EJ
Arch Neurol; 2007 Dec; 64(12):1771-6. PubMed ID: 18071042
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
[TBL] [Abstract][Full Text] [Related]
16. Heteromeric α7β2 Nicotinic Acetylcholine Receptors in the Brain.
Wu J; Liu Q; Tang P; Mikkelsen JD; Shen J; Whiteaker P; Yakel JL
Trends Pharmacol Sci; 2016 Jul; 37(7):562-574. PubMed ID: 27179601
[TBL] [Abstract][Full Text] [Related]
17. Unique pharmacology of heteromeric α7β2 nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes.
Zwart R; Strotton M; Ching J; Astles PC; Sher E
Eur J Pharmacol; 2014 Mar; 726():77-86. PubMed ID: 24485886
[TBL] [Abstract][Full Text] [Related]
18. Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer's disease.
Liu W; Li J; Yang M; Ke X; Dai Y; Lin H; Wang S; Chen L; Tao J
Alzheimers Res Ther; 2022 Apr; 14(1):53. PubMed ID: 35418161
[TBL] [Abstract][Full Text] [Related]
19. α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties.
Thomsen MS; Zwart R; Ursu D; Jensen MM; Pinborg LH; Gilmour G; Wu J; Sher E; Mikkelsen JD
PLoS One; 2015; 10(6):e0130572. PubMed ID: 26086615
[TBL] [Abstract][Full Text] [Related]
20. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y
J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
